Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Panzeri

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Oncology|November 7, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinomaValentina Panzeri, Isabella Manni, Alessia Capone, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growthDamon Fard, Erika Testa, Valentina Panzeri, et al.
Cells|December 3, 2020
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular FeaturesLivia Archibugi, Veronica Ruta, Valentina Panzeri, et al.
Cell Reports. Medicine|February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancerVeronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Oncology|November 7, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinomaValentina Panzeri, Isabella Manni, Alessia Capone, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growthDamon Fard, Erika Testa, Valentina Panzeri, et al.
Cells|December 3, 2020
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular FeaturesLivia Archibugi, Veronica Ruta, Valentina Panzeri, et al.
Cell Reports. Medicine|February 7, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancerVeronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Pageof 2